Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.
Amita Gupta and colleagues discuss priorities in clinical research aimed at improving tuberculosis prevention and treatment in pregnant women, children, and people with HIV.
Saved in:
| Main Authors: | Amita Gupta, Michael D Hughes, Anthony J Garcia-Prats, Katherine McIntire, Anneke C Hesseling |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-08-01
|
| Series: | PLoS Medicine |
| Online Access: | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1002882&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa.
by: Dominique J Pepper, et al.
Published: (2011-05-01) -
ANTITUBERCULOSIS DRUG DOSAGE FORMS: RANGE, KEY BENEFITS AND PROSPECTS OF TECHNOLOGICAL IMPROVEMENT
by: M. E. Kim, et al.
Published: (2016-09-01) -
COVID-19 vaccine barriers among pregnant and lactating refugee women: a case study
by: Elisabeth Williams, et al.
Published: (2025-07-01) -
Study of the pharmacokinetics of antituberculosis drug Biomairin
by: Sh. A. Shomurotov, et al.
Published: (2018-11-01) -
Liver Injury Associated with Antituberculosis Medications
by: Syifa Mustika, et al.
Published: (2025-07-01)